Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 17, 2024 17:51 ET
Attention Jabil Inc. Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Jabil Inc. ("Jabil" or the "Company") (NYSE: JBL). investors that the law firm has initiated an investigation on behalf of investors that lost money on their Jabil stock. Jabil investors are encouraged to contact the...
May 17, 2024 17:51 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Avangrid, Inc. By Iberdrola, S.A.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Avangrid, Inc. (“Avangrid” or the “Company”) (NYSE: “AGR”) stock purchased prior to May 17, 2024. You are hereby notified that Levi & Korsinsky,...
May 17, 2024 17:48 ET
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; June 21, 2024 deadline.
The Portnoy Law Firm advises Lincoln National Corporation (“Lincoln National” or the “Company”) (NYSE: LNC) investors that a lawsuit was filed on behalf of investors that purchased Lincoln securities between November 4, 2020 and November 2, 2022,...
May 17, 2024 17:39 ET
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that the Québec Superior Court (Commercial...
May 17, 2024 17:30 ET
Millicom (Tigo) share repurchase activity  
Millicom (Tigo) share repurchase activity Luxembourg, May 17, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 36,701 of its Swedish Depository Receipts (SDRs) between May 13, 2024 and May 17,...
May 17, 2024 17:15 ET
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today...
May 17, 2024 17:10 ET
Clairvest Partners with ECL Entertainment to Acquire Wyoming Downs
Clairvest Group Inc. (TSX: CVG) (“CVG”) today announced that it, together with Clairvest Equity Partners VI (“CEP VI”, collectively “Clairvest”) and ECL Entertainment, LLC (“ECL”), have acquired Wyoming Downs, a licensed live horse racing and...
May 17, 2024 17:00 ET
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Services Business
Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), announced today that it has delivered a termination notice with respect to its previously...
May 17, 2024 17:00 ET
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today disclosed that the Company received notice on May 16,...
May 17, 2024 17:00 ET
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that the U.S. District Court for the Western District...
May 17, 2024 17:00 ET
Hemlo Explorers Announces Listing on the CSE
Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to announce that it has received final approval from the Canadian Securities Exchange (the “CSE”) to list the Company’s common shares (“Common Shares”) on the CSE (the “Listing”). In...
May 17, 2024 17:00 ET
Plus Therapeutics Announces New Employment Inducement Grants
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that on May 8, 2024,...
May 17, 2024 17:00 ET
Titan Provides Update on Planned Merger with Conavi
Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is providing an update on its planned merger with Conavi Medical Inc. (“Conavi”) pursuant to the definitive amalgamation agreement (the “Amalgamation Agreement”) dated March 17, 2024 (the...
May 17, 2024 16:58 ET
Statement on Chairman Glenn Thompson's 'Corrupt' House Farm Bill Released Today
Today, the Organization for Competitive Markets and Competitive Markets Action released the following statement in response to U.S. House Committee on Agriculture Glenn "G.T." Thompson's Farm Bill made public earlier in the day: "Chairman's...
May 17, 2024 16:48 ET
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors with Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....
May 17, 2024 16:42 ET
MERGER INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Avangrid, Inc. (AGR) and Encourages Investors to Contact the Firm
Kaskela Law LLC announces that it is investigating Avangrid, Inc. (NYSE: AGR) on behalf of the company’s shareholders. On May 17, 2024, Avangrid announced that it had agreed to be acquired by Iberdrola, S.A. at a price of $35.75 per share in cash....
May 17, 2024 16:35 ET
ExGen: Phoenix Raises US$80 Million for Construction of the Empire Mine, Idaho
ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) is pleased to provide an update in respect of Phoenix Copper Ltd.’s (“Phoenix”) exploration and development activities at the Empire Mine Project in Custer County, Idaho, USA,...
May 17, 2024 16:35 ET
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment Opportunities with Airdrop Bonus
In an ever-evolving investment landscape, AthenaDexFi emerges as a beacon of innovation, offering investors a diverse array of investment avenues tailored for success. Today, AthenaDexFi proudly announces the launch of its highly anticipated...
May 17, 2024 16:33 ET
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced it has closed its previously announced...
May 17, 2024 16:30 ET
DBV Technologies Announces Plan to Implement ADS Ratio Change
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage biopharmaceutical company focused on...